BBA
TYRA icon

Baker Bros. Advisors’s Tyra Biosciences TYRA Stock Holding History

Baker Bros. Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Hold
10,607
– – ﹤0.01% 83
2026
Q1 		$406K Hold
10,607
– – ﹤0.01% 83
2025
Q4 		$279K Hold
10,607
– – ﹤0.01% 84
2025
Q3 		$148K Hold
10,607
– – ﹤0.01% 88
2025
Q2 		$102K Hold
10,607
– – ﹤0.01% 86
2025
Q1 		$98.6K Hold
10,607
– – ﹤0.01% 86
2024
Q4 		$147K Hold
10,607
– – ﹤0.01% 94
2024
Q3 		$249K Hold
10,607
– – ﹤0.01% 92
2024
Q2 		$170K Hold
10,607
– – ﹤0.01% 94
2024
Q1 		$174K Hold
10,607
– – ﹤0.01% 86
2023
Q4 		$147K Buy
+10,607
New +$137K ﹤0.01% 83

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Baker Bros. Advisors's TYRA Position: Q2 2026 in Review

Baker Bros. Advisors held its Tyra Biosciences (TYRA) position steady in Q2 2026 at 10,607 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #83.

Baker Bros. Advisors first reported a position in TYRA in Q4 2023 and has held it in 11 quarters since. The position peaked at $406K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Baker Bros. Advisors held 10,607 shares of Tyra Biosciences worth $339K as of Q2 2026.
  • Baker Bros. Advisors left its Tyra Biosciences share count unchanged in Q2 2026.
  • Tyra Biosciences made up ﹤0.01% of Baker Bros. Advisors's portfolio in Q2 2026, its #83 holding.
  • Baker Bros. Advisors first reported a position in Tyra Biosciences in Q4 2023 and has held it in 11 quarters since.
  • Baker Bros. Advisors's Tyra Biosciences position peaked at $406K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.